Total Payments
$97,563
2024 Payments
$22,780
Companies
19
Transactions
83
Medicare Patients
785
Medicare Billing
$65,909
Payment Breakdown by Category
Consulting$72,443 (74.3%)
Research$16,430 (16.8%)
Other$5,500 (5.6%)
Food & Beverage$2,291 (2.3%)
Travel$810.00 (0.8%)
Education$89.99 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $72,443 | 41 | 74.3% |
| Unspecified | $16,430 | 6 | 16.8% |
| Honoraria | $5,500 | 2 | 5.6% |
| Food and Beverage | $2,291 | 32 | 2.3% |
| Travel and Lodging | $810.00 | 1 | 0.8% |
| Education | $89.99 | 1 | 0.1% |
Payments by Type
General
$81,133
77 transactions
Research
$16,430
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Research & Development, LLC | $30,354 | 16 | $0 (2024) |
| Photocure Inc | $23,414 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $17,585 | 11 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $16,430 | 6 | $0 (2024) |
| Janssen Global Services, LLC | $4,765 | 5 | $0 (2024) |
| Provepharm Inc. | $2,580 | 3 | $0 (2023) |
| UroGen Pharma, Inc. | $542.21 | 4 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $505.00 | 1 | $0 (2021) |
| Boston Scientific Corporation | $347.78 | 4 | $0 (2023) |
| Astellas Pharma US Inc | $196.21 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22,780 | 18 | Janssen Research & Development, LLC ($10,230) |
| 2023 | $43,051 | 29 | Merck Sharp & Dohme LLC ($14,335) |
| 2022 | $20,937 | 11 | Janssen Research & Development, LLC ($13,640) |
| 2021 | $4,300 | 4 | Janssen Global Services, LLC ($3,795) |
| 2020 | $3,923 | 4 | Photocure Inc ($3,850) |
| 2019 | $1,811 | 6 | Photocure Inc ($1,500) |
| 2018 | $492.54 | 7 | Dendreon Pharmaceuticals LLC ($123.66) |
| 2017 | $269.39 | 4 | BOSTON SCIENTIFIC CORPORATION ($194.79) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Janssen Scientific Affairs, LLC | — | — | Cash or cash equivalent | $1,860.00 | Research |
| 11/29/2024 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| 11/25/2024 | Janssen Scientific Affairs, LLC | — | — | Cash or cash equivalent | $1,240.00 | Research |
| 11/12/2024 | Photocure Inc | CYSVIEW (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $2,480.00 | General |
| 09/25/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $915.00 | General |
| 06/30/2024 | Photocure Inc | CYSVIEW (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: ONCOLOGY | ||||||
| 05/24/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $2,170.00 | General |
| 05/14/2024 | Photocure Inc | CYSVIEW (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: ONCOLOGY | ||||||
| 05/06/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| 05/05/2024 | Photocure Inc | CYSVIEW (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| 03/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $915.00 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,240.00 | General |
| 02/14/2024 | Photocure Inc | CYSVIEW (Drug) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: ONCOLOGY | ||||||
| 02/05/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $610.00 | General |
| 01/15/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $810.00 | General |
| 01/04/2024 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $620.00 | General |
| 12/15/2023 | Provepharm Inc. | BLUDIGO (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: MARKER DYE | ||||||
| 11/16/2023 | Photocure Inc | CYSVIEW (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2023 | Janssen Scientific Affairs, LLC | — | — | Cash or cash equivalent | $1,240.00 | Research |
| 10/11/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,440.00 | General |
| 10/03/2023 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,240.00 | General |
| 09/27/2023 | Photocure Inc | CYSVIEW (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,440.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 154 | 174 | $63,615 | $13,086 |
| 2022 | 4 | 190 | 217 | $79,297 | $17,334 |
| 2021 | 6 | 224 | 268 | $89,669 | $20,541 |
| 2020 | 8 | 217 | 247 | $70,989 | $14,948 |
Total Patients
785
Total Services
906
Medicare Billing
$65,909
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 48 | 48 | $19,920 | $4,541 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 44 | 56 | $15,120 | $4,367 | 28.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 25 | 33 | $16,764 | $2,001 | 11.9% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 19 | 19 | $10,317 | $1,755 | 17.0% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 18 | 18 | $1,494 | $422.57 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 85 | 109 | $29,430 | $8,141 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 59 | 59 | $24,485 | $5,776 | 23.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 32 | 35 | $17,780 | $2,072 | 11.7% |
| 55700 | Biopsy of prostate gland | Facility | 2022 | 14 | 14 | $7,602 | $1,345 | 17.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 86 | 124 | $33,480 | $9,390 | 28.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 68 | 68 | $28,220 | $6,911 | 24.5% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 30 | 35 | $17,780 | $2,051 | 11.5% |
| 55700 | Biopsy of prostate gland | Facility | 2021 | 11 | 11 | $5,973 | $1,168 | 19.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 16 | 17 | $3,111 | $664.68 | 21.4% |
| 76872 | Ultrasound of pelvic region through rectum | Facility | 2021 | 13 | 13 | $1,105 | $355.94 | 32.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 71 | 88 | $23,760 | $4,678 | 19.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 25 | 25 | $10,375 | $2,442 | 23.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 23 | 27 | $5,275 | $1,777 | 33.7% |
| 55700 | Biopsy of prostate gland | Facility | 2020 | 16 | 16 | $8,688 | $1,753 | 20.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 25 | 25 | $6,825 | $1,502 | 22.0% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2020 | 16 | 18 | $9,144 | $1,157 | 12.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 24 | 29 | $5,307 | $1,104 | 20.8% |
| 76872 | Ultrasound of rectum | Facility | 2020 | 17 | 19 | $1,615 | $534.47 | 33.1% |
About Dr. Stephen Williams, M.D
Dr. Stephen Williams, M.D is a Urology healthcare provider based in League City, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2008. The National Provider Identifier (NPI) number assigned to this provider is 1952578536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Williams, M.D has received a total of $97,563 in payments from pharmaceutical and medical device companies, with $22,780 received in 2024. These payments were reported across 83 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($72,443).
As a Medicare-enrolled provider, Williams has provided services to 785 Medicare beneficiaries, totaling 906 services with total Medicare billing of $65,909. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location League City, TX
- Active Since 05/13/2008
- Last Updated 05/18/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1952578536
Products in Payments
- CYSVIEW (Drug) $18,064
- KEYTRUDA (Biological) $9,150
- Cysview (Drug) $5,350
- BLUDIGO (Drug) $2,580
- JELMYTO (Drug) $337.70
- PROVENGE (Drug) $123.66
- 16 FR. FLEXIBLE VIDEO CYSTOSCOPE (Device) $110.80
- GENERAL - ERECTILE DYSFUNCTION (Device) $107.82
- Erleada (Drug) $107.69
- Cook Medical Stents (Device) $93.43
- PROLARIS (Device) $88.82
- GREENLIGHT (Device) $86.97
- Ligation Solutions: Weck & Horizon brands (Device) $84.01
- DARZALEX (Drug) $75.22
- BARDIA (Device) $66.46
- Mobile Cryoblation Services (Device) $56.59
- UroNav (Device) $56.10
- XTANDI (Drug) $44.73
- Uronav (Device) $40.06
- MYRBETRIQ (Drug) $21.78
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.